Novartis (NVS)

74.15 -0.86  -1.15%  May 17, 8:00PM
Add to Watchlists Create an Alert

Novartis Return on Equity:

14.52% for March 31, 2013
View Full Chart

Novartis Return on Equity Chart

    Novartis Historical Return on Equity Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 14.52%
    Dec. 31, 2012 14.35%
    Sept. 30, 2012 13.14%
    June 30, 2012 13.17%
    March 31, 2012 13.11%
    Dec. 31, 2011 13.91%
    Sept. 30, 2011 15.41%
    June 30, 2011 15.61%
    March 31, 2011 15.75%
    Dec. 31, 2010 16.44%
    Sept. 30, 2010 17.24%
    June 30, 2010 17.91%
    March 31, 2010 17.84%
    Dec. 31, 2009 16.30%
    Sept. 30, 2009 15.20%
    June 30, 2009 15.29%
    March 31, 2009 15.80%
    Dec. 31, 2008 16.32%
    Sept. 30, 2008 15.10%
    June 30, 2008 25.35%
       
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro

    About Return on Equity (ROE)

    Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

    ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

    Investors generally are interested in company's that have high, increasing returns on equity.
    Learn More

    Get data for

    NVS Return on Equity Benchmarks

    Companies
    Pfizer 17.87%
    Sanofi
    Merck 11.28%

    NVS Return on Equity Rankings

    Overall 85th percentile
    1157 of 8007
    Sector 84th percentile
    106 of 685 in Healthcare
    Industry 79th percentile
    11 of 54 in Drug Manufacturers - Major

    NVS Return on Equity Range, Past 5 Years

    Minimum 13.11% Mar 2012
    Maximum 25.35% Jun 2008
    Average 15.89%